Contract development and manufacturing organisations (CDMOs) are facing mounting pressures to streamline production processes while adhering to increasingly stringent quality…
The European Society of Cardiology (ESC) Annual Meeting 2025, held from August 29 to September 1 in Madrid, Spain, showcased…
This podcast explores how real-world data (RWD) fills gaps in understanding maternal and infant health, especially since pregnant individual often…
This series explores the innovations, logistics and behind-the-scenes operations that keep clinical research moving with expert insight from Oximio. In…
This development is driven by the rise of personalized medicine, orphan drugs, and advanced biologics, each requiring highly flexible and…
As the world of small molecule pharmaceuticals advances, the combination of high pharmacological activity with greater selectivity is delivering therapeutic…
The evaluation of new treatment effectiveness and patient safety has traditionally been dominated by clinical trials. These trials, particularly randomized…
The pharma sector contributes 5% of global GHG emissions1, a fact that has helped drive the top 46% of pharmaceutical…
The World Health Organization (WHO) has drafted a priority pathogen list to direct funding and resources to the areas that…
Migrating clinical studies to a new platform requires careful planning and is the focus of episode four in the Zelta…
